[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2009004460A - Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos. - Google Patents

Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.

Info

Publication number
MX2009004460A
MX2009004460A MX2009004460A MX2009004460A MX2009004460A MX 2009004460 A MX2009004460 A MX 2009004460A MX 2009004460 A MX2009004460 A MX 2009004460A MX 2009004460 A MX2009004460 A MX 2009004460A MX 2009004460 A MX2009004460 A MX 2009004460A
Authority
MX
Mexico
Prior art keywords
analyte
labeled
species
analytes
immunoassay
Prior art date
Application number
MX2009004460A
Other languages
English (en)
Inventor
Phillip G Mattingly
Maciej Adamczyk
Roy Jeffrey Brashear
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2009004460A publication Critical patent/MX2009004460A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

La invención proporciona, entre otras cosas, un método de ensayo que comprensa la presencia de anticuerpos endógenos, por ejemplo auto-anticuerpos, los cuales podrían comprometer de otra manera la medición de un analito en una muestra biológica. En una modalidad, este método implica el uso de dos entidades marcadas: un agente de detección marcado y un anticuerpo específico de la especie marcado, en donde el anticuerpo especifico de la especie marcado es específico para la especie a partir de la cual se obtuvo la muestra biológica. El analito de muestra se enlaza con el agente de detección y con cualesquiera auto-anticuerpos anti-analito presentes en la muestra. El analito enlazado con los auto-anticuerpos se detecta mediante el anticuerpo específico de la especie, opcionalmente marcado.
MX2009004460A 2006-10-26 2007-10-17 Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos. MX2009004460A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85456906P 2006-10-26 2006-10-26
PCT/US2007/081608 WO2008051762A2 (en) 2006-10-26 2007-10-17 Immunoassay of analytes in samples containing endogenous anti-analyte antibodies

Publications (1)

Publication Number Publication Date
MX2009004460A true MX2009004460A (es) 2009-07-09

Family

ID=39325250

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004460A MX2009004460A (es) 2006-10-26 2007-10-17 Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.

Country Status (6)

Country Link
US (1) US8357495B2 (es)
EP (1) EP2097750A2 (es)
JP (1) JP5057402B2 (es)
CA (1) CA2667012A1 (es)
MX (1) MX2009004460A (es)
WO (1) WO2008051762A2 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103203048A (zh) 2005-12-13 2013-07-17 埃克塞拉医学有限责任公司 用于从血液中体外去除病原微生物、炎性细胞或炎性蛋白质的方法
CA2667012A1 (en) 2006-10-26 2008-05-02 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US7776605B2 (en) 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
US20090053736A1 (en) * 2007-08-21 2009-02-26 Mattingly Phillip G Homogeneous Chemiluminescent Immunoassay for Analysis of Iron Metalloproteins
WO2009085356A2 (en) * 2007-10-01 2009-07-09 University Of Southern California Usc Stevens Methods of using and constructing nanosensor platforms
US20090286256A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratories Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
US20100105150A1 (en) * 2008-10-24 2010-04-29 Abbott Laboratories Isolated human autoantibodies to neutrophil gelatinase-associated lipocalin (ngal) and methods and kits for the detection of human autoantibodies to ngal
US20100204062A1 (en) * 2008-11-07 2010-08-12 University Of Southern California Calibration methods for multiplexed sensor arrays
US20100256344A1 (en) * 2009-04-03 2010-10-07 University Of Southern California Surface modification of nanosensor platforms to increase sensitivity and reproducibility
US20110027453A1 (en) 2009-07-02 2011-02-03 Dexcom, Inc. Continuous analyte sensors and methods of making same
EP2515110B1 (en) * 2009-11-19 2015-03-25 Ushio Denki Kabushiki Kaisha Fluoroimmunoassay method
JP5792181B2 (ja) 2009-11-23 2015-10-07 ブリマン、ミカイル 炭素系電極の制御された電気化学的活性化
CN106178161B (zh) 2009-12-01 2020-12-22 艾克塞拉医疗公司 使用固定于表面的多糖从血液中去除细胞因子的方法
US20110136141A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US9199234B2 (en) * 2011-05-27 2015-12-01 Abbott Point Of Care Inc. TSH antibodies for point-of-care immunoassay formats
CA2836236C (en) * 2011-05-27 2020-04-28 Abbott Point Of Care Inc. Tsh immunoassays and processes for performing tsh immunoassays in the presence of endogenous contaminants in restricted wash formats
US10641768B2 (en) * 2011-07-08 2020-05-05 Abbott Japan Co. Ltd. Methods and kits for decreasing interferences from leukocytes in specific binding assays
US9638663B2 (en) 2011-07-25 2017-05-02 Proxim Diagnostics Corporation Cartridge for diagnostic testing
US9140695B2 (en) * 2012-01-18 2015-09-22 University Of Utah Research Foundation Methods for analysis of free and autoantibody-bound biomarkers and associated compositions, devices, and systems
DK2861273T3 (da) 2012-06-13 2017-11-27 Exthera Medical Corp Anvendelse af heparin og kulhydrater til behandling af cancer.
WO2014055350A2 (en) * 2012-10-01 2014-04-10 Bhc Technology Holdings Llc Compositions systems and methods that detect and/or remove cross-reactive antibodies from a biological sample
CN105209616A (zh) 2013-03-14 2015-12-30 雅培制药有限公司 用于改进的抗体检测的hcv ns3重组抗原及其突变体
JP6505076B2 (ja) 2013-03-14 2019-04-24 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ Ｈｃｖ抗原−抗体組み合わせアッセイおよびこれに使用するための方法および組成物
EP2971046A4 (en) 2013-03-14 2016-11-02 Abbott Lab MONOCLONAL ANTIBODIES WITH LIPID BINDING TO THE HEART OF HCV
JP6648009B2 (ja) 2013-06-24 2020-02-14 エクステラ・メディカル・コーポレーション マンノース被覆基材を含有する血液濾過システム
US9945847B2 (en) 2013-09-23 2018-04-17 Assaypro, Llc Immunoassays using over-labeled fluorescent probes
JP6806563B2 (ja) 2013-11-08 2021-01-06 エクステラ・メディカル・コーポレーション 吸着媒体を使用する感染症の診断法
DE15782250T1 (de) 2014-04-24 2017-08-10 Exthera Medical Corporation Verfahren zur Entfernung von Bakterien aus Blut unter Verwendung einer hohen Durchflussrate
KR20170060062A (ko) 2014-09-22 2017-05-31 엑스테라 메디컬 코퍼레이션 웨어러블 혈액관류 장치
GB201522839D0 (en) * 2015-12-23 2016-02-03 Randox Lab Ltd And Randox Teoranta Method
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
US11604192B2 (en) * 2017-03-20 2023-03-14 Diasorin Italia S.P.A. Immunoassay for detecting Zika virus infection
US20200278349A1 (en) * 2019-02-28 2020-09-03 University Of Utah Research Foundation Biohazard analyzer
BR112021021141A2 (pt) 2019-05-16 2021-12-14 Exthera Medical Corp Método para modular estrutura glicocalyx endotelial
CN111077323A (zh) * 2020-01-12 2020-04-28 天津市宝坻区人民医院 消除胰岛素自身抗体干扰的胰岛素测定试剂盒
WO2023182520A1 (ja) * 2022-03-25 2023-09-28 積水メディカル株式会社 免疫学的分析方法、複合体、複合体の製造方法及び免疫学的分析用試薬

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4637880A (en) 1981-11-30 1987-01-20 Cordis Laboratories, Inc. Apparatus and method for therapeutic immunodepletion
ES2063735T3 (es) 1986-10-22 1995-01-16 Abbott Lab Sales de acridinio quimioluminiscentes.
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5132405A (en) 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
JPS6412935A (en) 1987-07-02 1989-01-17 Mitsubishi Electric Corp Constant-speed travel device for vehicle
AU609241B2 (en) 1988-01-29 1991-04-26 Abbott Laboratories Ion-capture assays and devices
US5006309A (en) 1988-04-22 1991-04-09 Abbott Laboratories Immunoassay device with liquid transfer between wells by washing
US5244630A (en) 1988-04-22 1993-09-14 Abbott Laboratories Device for performing solid-phase diagnostic assay
US5089424A (en) 1988-06-14 1992-02-18 Abbott Laboratories Method and apparatus for heterogeneous chemiluminescence assay
US5063081A (en) 1988-11-14 1991-11-05 I-Stat Corporation Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
ES2063353T3 (es) 1989-04-14 1995-01-01 Procedes Petroliers Petrochim Procedimiento de vapocraqueo de hidrocarburos.
CA1341592C (en) 1989-07-07 2009-04-14 Abbott Laboratories Ion capture reagents and methods for performing binding assays
JPH0746996A (ja) * 1993-08-05 1995-02-21 Sanko Junyaku Kk 合成ペプチドを免疫原とするモノクローナル抗体
EP0651253A1 (en) 1993-11-02 1995-05-03 Abbott Laboratories Immunoassay for the detection of human autoantibodies
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5561049A (en) * 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US5795725A (en) 1995-04-18 1998-08-18 Biosite Diagnostics Incorporated Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays
ATE281648T1 (de) 1995-04-18 2004-11-15 Biosite Diagnostics Inc Verfahren zum assay von troponin i und t und komplexen von troponin i und t und auswahl von antikörpern zur verwendung in immunoassays
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US7285418B2 (en) 1996-06-25 2007-10-23 Hytest Ltd. Method and kit for the diagnosis of troponin I
DE19651093C2 (de) * 1996-12-09 1999-06-10 Brahms Diagnostica Gmbh Rezeptorbindungsassay zum Nachweis von TSH-Rezeptor-Autoantikörpern sowie Reagenziensatz für die Durchführung eines solchen Rezeptorbindungsassays
US6682648B1 (en) 1997-08-12 2004-01-27 University Of Southern California Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures
US6303325B1 (en) * 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
ATE221076T1 (de) 1998-06-01 2002-08-15 Roche Diagnostics Corp Redox-reversible imidazol-osmiumkomplex-konjugate
US6309888B1 (en) 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
US6645465B2 (en) 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
AU1241901A (en) 1999-11-24 2001-06-04 Biotronics Technologies, Inc. Devices and methods for detecting analytes using electrosensor having capture reagent
AU4465001A (en) * 2000-03-30 2001-10-15 Nippon Kayaku Kabushiki Kaisha Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor
JP4363740B2 (ja) * 2000-03-31 2009-11-11 雪印乳業株式会社 特異的ＩｇＥ抗体測定方法
ATE398678T1 (de) * 2000-04-10 2008-07-15 Merk Und Kollegen Gmbh Lab Dr Fusionsprotein zur gleichzeitigen erkennung von humanen autoantikörpern
FR2810739B1 (fr) 2000-06-26 2007-01-26 Centre Nat Rech Scient Immunodosage electrochimiques a l'aide de marqueurs metalliques colloidaux
GB0017641D0 (en) 2000-07-18 2000-09-06 Medigene Oy Peptides and their use
US6887714B2 (en) 2000-10-16 2005-05-03 Board Of Trustees Of The University Of Arkansas, N.A. Microvolume immunoabsorbant assays with amplified electrochemical detection
AU2002309647C1 (en) 2001-05-25 2008-09-11 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to trail receptors
US6896872B2 (en) 2001-06-27 2005-05-24 Svetlana A. Dambinova Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
US7189516B2 (en) * 2001-08-17 2007-03-13 Luminex Corporation Method for characterizing autoimmune disorders
US20030100036A1 (en) 2001-11-08 2003-05-29 Aristo Vojdani Saliva immunoassay for detection of antibodies for cardiovascular disease
US7419821B2 (en) 2002-03-05 2008-09-02 I-Stat Corporation Apparatus and methods for analyte measurement and immunoassay
US20040018577A1 (en) 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
US7196169B2 (en) 2002-10-11 2007-03-27 Queen's University At Kingston Isolated post-translationally modified mammalian proteins for monitoring and diagnosing muscle damage
EP1619498B1 (en) 2003-04-16 2011-01-05 Ono Pharmaceutical Co., Ltd. Method of screening remedy for heart disease and medicinal composition for treating heart disease
FI20030652A0 (fi) 2003-04-30 2003-04-30 Susann Eriksson Parannettu immunomääritys
US6924373B2 (en) 2003-05-02 2005-08-02 Asiagen Corporation DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds
US7723099B2 (en) 2003-09-10 2010-05-25 Abbott Point Of Care Inc. Immunoassay device with immuno-reference electrode
US7682833B2 (en) 2003-09-10 2010-03-23 Abbott Point Of Care Inc. Immunoassay device with improved sample closure
CA2537818A1 (en) 2003-09-15 2005-03-31 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
US20050069958A1 (en) * 2003-09-26 2005-03-31 Mills Rhonda A. Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
US20050181451A1 (en) 2004-02-12 2005-08-18 Bates Harold M. Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
US7279281B2 (en) 2004-06-01 2007-10-09 The Regents Of The University Of Michigan Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
US20060024744A1 (en) * 2004-07-28 2006-02-02 Mills Rhonda A Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte
SE0402536D0 (sv) * 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
US7731965B2 (en) * 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
US7291854B2 (en) 2005-07-18 2007-11-06 Trinity Health Corporation Radiation attenuation corridor
US20070172888A1 (en) 2006-01-25 2007-07-26 Klaus Hallermayer Measuring troponin antibodies to assess cardiovascular risk
WO2007085411A1 (en) 2006-01-25 2007-08-02 Roche Diagnostics Gmbh Anti-troponin antibodies and cardiovascular risk
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
CA2667012A1 (en) 2006-10-26 2008-05-02 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US7776605B2 (en) 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
MX2009006744A (es) 2006-12-22 2009-06-30 Abbott Lab Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.
US8183002B2 (en) 2009-12-03 2012-05-22 Abbott Laboratories Autoantibody enhanced immunoassays and kits

Also Published As

Publication number Publication date
WO2008051762A2 (en) 2008-05-02
JP5057402B2 (ja) 2012-10-24
EP2097750A2 (en) 2009-09-09
US20090246800A1 (en) 2009-10-01
CA2667012A1 (en) 2008-05-02
JP2010508516A (ja) 2010-03-18
US8357495B2 (en) 2013-01-22
WO2008051762A3 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
MX2009004460A (es) Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
CY1126069T1 (el) Προσδιορισμος για αντισωματα ιου jc
ATE449337T1 (de) Assay
WO2006126008A3 (en) Improved immunoassay methods
EP1767941A4 (en) CHROMATOGRAPHIC DETECTION APPARATUS, TEST METHOD, AND KIT USING THE SAME
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
ATE432947T1 (de) Menschliche antikörper als detektionsreagenzien
DE60219207D1 (de) Diagnostisches testverfahren
MX344053B (es) Metodos para determinar isotipos de anticuerpos anti-farmacos.
MX2013003161A (es) Dispositivos, metodos y kits de inmunocromatografia.
HK1106025A1 (en) Method for increasing the dynamic measuring range of test elements, especially immunological test elements, that are based on specific bonding reactions
ATE529752T1 (de) Antikörperquantifizierung
WO2006047591A3 (en) Rapid microfluidic assay for analyte interactions
DE60013320D1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
WO2008101177A3 (en) Ige antibodies to chimeric or humanized igg therapeutic monoclonal antibodies as a screening test for anaphylaxis
ATE339687T1 (de) Immunologische verfahren, vorrichtungen und reagenzien
WO2010006201A3 (en) Methods of reducing non-specific interaction in metal nanoparticle assays
WO2007076013A3 (en) Homocysteine immunoassay
EA201370030A1 (ru) Бифункциональный количественный анализ in vitro связывания мишени для обнаружения нейтрализующих антител к антителам-мишеням
WO2005019831A3 (en) Methods for reducing complexity of a sample using small epitope antibodies
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка
BRPI0519354A2 (pt) mÉtodo para detecÇço de um anticorpo terapÊutico e uso de um anticorpo
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
EA202192229A1 (ru) Селективное оптическое обнаружение органических анализируемых веществ в жидкостях
WO2014159920A4 (en) A device and method for the detection and diagnosis of aggressive and metastatic cancer and cancer stem cells employing podocalyxin and tra biomarkers

Legal Events

Date Code Title Description
FG Grant or registration